Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 13, 2013 - Issue sup1: Challenges and Promises in Multiple Myeloma Biological Drug Development and Personalization
Submit an article Journal homepage
339
Views
63
CrossRef citations to date
0
Altmetric
Reviews

Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma

Nicola AmodioMagna Graecia University and T. Campanella Cancer Center, Department of Experimental and Clinical Medicine, Medical Oncology Unit, Viale Europa, 88100 Catanzaro, Italy+39 0961 3697029; +39 0961 3697341; [email protected]
,
Maria Teresa Di MartinoMagna Graecia University and T. Campanella Cancer Center, Department of Experimental and Clinical Medicine, Medical Oncology Unit, Viale Europa, 88100 Catanzaro, Italy+39 0961 3697029; +39 0961 3697341; [email protected]
,
Antonino NeriUniversity of Milan, Department of Clinical Sciences and Community Health, Hematology 1, IRCCS Policlinico Foundation, Milan, Italy
,
Pierosandro TagliaferriMagna Graecia University and T. Campanella Cancer Center, Department of Experimental and Clinical Medicine, Medical Oncology Unit, Viale Europa, 88100 Catanzaro, Italy+39 0961 3697029; +39 0961 3697341; [email protected]
&
Pierfrancesco TassoneMagna Graecia University and T. Campanella Cancer Center, Department of Experimental and Clinical Medicine, Medical Oncology Unit, Viale Europa, 88100 Catanzaro, Italy+39 0961 3697029; +39 0961 3697341; [email protected];Temple University, Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Philadelphia, PA, USA
, MD
Pages S125-S137 | Published online: 22 May 2013

Citations (63)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Marta Lionetti & Antonino Neri. (2017) Utilizing next-generation sequencing in the management of multiple myeloma. Expert Review of Molecular Diagnostics 17:7, pages 653-663.
Read now
Xiaoying Zhang, Yafang Chen, Pan Zhao, Li Zang, Zhiqing Zhang & Xiaofang Wang. (2017) MicroRNA-19a functions as an oncogene by regulating PTEN/AKT/pAKT pathway in myeloma. Leukemia & Lymphoma 58:4, pages 932-940.
Read now
Nicola Amodio, Patrizia D’Aquila, Giuseppe Passarino, Pierfrancesco Tassone & Dina Bellizzi. (2017) Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation. Expert Opinion on Therapeutic Targets 21:1, pages 91-101.
Read now
Maria Teresa Di Martino, Marco Rossi, Daniele Caracciolo, Annamaria Gullà, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2016) Mir-221/222 are promising targets for innovative anticancer therapy. Expert Opinion on Therapeutic Targets 20:9, pages 1099-1108.
Read now
Maria Teresa Di Martino, Mariamena Arbitrio, Pietro Hiram Guzzi, Mario Cannataro, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2016) Experimental treatment of multiple myeloma in the era of precision medicine. Expert Review of Precision Medicine and Drug Development 1:1, pages 37-51.
Read now
Nicola Amodio, Dina Bellizzi, Marzia Leotta, Lavinia Raimondi, Lavinia Biamonte, Patrizia D’Aquila, Maria Teresa Di Martino, Teresa Calimeri, Marco Rossi, Marta Lionetti, Emanuela Leone, Giuseppe Passarino, Antonino Neri, Antonio Giordano, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2013) miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells. Cell Cycle 12:23, pages 3650-3662.
Read now

Articles from other publishers (57)

Yuyue Ren, Yijun Liu, Wanting He, Weiwei Zhao, Jiaqi Pan, Haiyan Gao, Yuying Li, Ying Zhang & Wei Wang. (2023) Expression of NEAT1 can be used as a predictor for Dex resistance in multiple myeloma patients. BMC Cancer 23:1.
Crossref
Maria Eugenia Gallo Cantafio, Roberta Torcasio, Giuseppe Viglietto & Nicola Amodio. (2023) Non-Coding RNA-Dependent Regulation of Mitochondrial Dynamics in Cancer Pathophysiology. Non-Coding RNA 9:1, pages 16.
Crossref
Francesca Alessandra Ambrosio, Giosuè Costa, Maria Eugenia Gallo Cantafio, Roberta Torcasio, Francesco Trapasso, Stefano Alcaro, Giuseppe Viglietto & Nicola Amodio. (2023) Natural Agents as Novel Potential Source of Proteasome Inhibitors with Anti-Tumor Activity: Focus on Multiple Myeloma. Molecules 28:3, pages 1438.
Crossref
Ram Singh, Yogesh Kumar Tyagi & Nidhi Yadav. (2023) Hydroxychloroquine: Chemistry and Medicinal Applications. HETEROCYCLES 106:3, pages 423.
Crossref
Ali Tavakoli Pirzaman, Pouyan Ebrahimi, Amir Hossein Hasanpour, Mahdi Shakeri, Bahareh Babajani, Zahra Pourali Ganji, Hedye Babaei, Amirhossein Rahmati, Rezvan Hosseinzadeh, Shahrbanoo Doostmohamadian & Sohrab Kazemi. (2023) miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance. Technology in Cancer Research & Treatment 22.
Crossref
Daniele Caracciolo, Giada Juli, Caterina Riillo, Adriana Coricello, Francesca Vasile, Sara Pollastri, Roberta Rocca, Francesca Scionti, Nicoletta Polerà, Katia Grillone, Mariamena Arbitrio, Nicoletta Staropoli, Basilio Caparello, Domenico Britti, Giovanni Loprete, Giosuè Costa, Maria Teresa Di Martino, Stefano Alcaro, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2022) Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin. Journal of Translational Medicine 20:1.
Crossref
Hongyan Ma, Liyun Shen, Hua Yang, Hongtao Gong & Xingjun Du. (2022) Circular RNA circPSAP functions as an efficient miR-331-3p sponge to regulate proliferation, apoptosis and bortezomib sensitivity of human multiple myeloma cells by upregulating HDAC4. Journal of Pharmacological Sciences 149:1, pages 27-36.
Crossref
Maria Teresa Di Martino, Mariamena Arbitrio, Daniele Caracciolo, Alessia Cordua, Onofrio Cuomo, Katia Grillone, Caterina Riillo, Giulio Caridà, Francesca Scionti, Caterina Labanca, Caterina Romeo, Maria Anna Siciliano, Maria D'Apolito, Cristina Napoli, Martina Montesano, Valentina Farenza, Valentina Uppolo, Michele Tafuni, Federica Falcone, Giuseppe D'Aquino, Natale Daniele Calandruccio, Francesco Luciano, Licia Pensabene, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2022) miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review. Molecular Therapy - Nucleic Acids 27, pages 1191-1224.
Crossref
Elisa Taiana, Maria Eugenia Gallo Cantafio, Vanessa Katia Favasuli, Cecilia Bandini, Giuseppe Viglietto, Roberto Piva, Antonino Neri & Nicola Amodio. (2021) Genomic Instability in Multiple Myeloma: A “Non-Coding RNA” Perspective. Cancers 13:9, pages 2127.
Crossref
Maria Teresa Di Martino, Caterina Riillo, Francesca Scionti, Katia Grillone, Nicoletta Polerà, Daniele Caracciolo, Mariamena Arbitrio, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2021) miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy. Cancers 13:7, pages 1587.
Crossref
Daniele Caracciolo, Caterina Riillo, Maria Teresa Di Martino, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2021) Alternative Non-Homologous End-Joining: Error-Prone DNA Repair as Cancer’s Achilles’ Heel. Cancers 13:6, pages 1392.
Crossref
Hanaa R.M. Attia, Amany H. Abdelrahman, Mona H. Ibrahim, Maha M. Eid, Ola M. Eid, Mohamed T. Sallam, Mosaad M. El Gammal & Mahmoud M. Kamel. (2020) Altered Expression of MicroRNAs in the Bone Marrow of Multiple Myeloma Patients and their Relationship to Cytogenetic Aberrations. Current Pharmaceutical Biotechnology 21:13, pages 1394-1401.
Crossref
Maria Teresa Di Martino, Mariamena Arbitrio, Daniele Caracciolo, Francesca Scionti, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2020) Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats. Molecular Therapy - Nucleic Acids 20, pages 73-85.
Crossref
Mohammad H. Pourhanifeh, Maryam Mahjoubin‐Tehran, Alimohammad Shafiee, Sarah Hajighadimi, Sanaz Moradizarmehri, Hamed Mirzaei & Zatollah Asemi. (2019) MicroRNAs and exosomes: Small molecules with big actions in multiple myeloma pathogenesis. IUBMB Life 72:3, pages 314-333.
Crossref
Lavinia Raimondi, Angela De Luca, Gianluca Giavaresi, Agnese Barone, Pierosandro Tagliaferri, Pierfrancesco Tassone & Nicola Amodio. (2020) Impact of Natural Dietary Agents on Multiple Myeloma Prevention and Treatment: Molecular Insights and Potential for Clinical Translation. Current Medicinal Chemistry 27:2, pages 187-215.
Crossref
Eugenio Morelli, Annamaria Gullà, Roberta Rocca, Cinzia Federico, Lavinia Raimondi, Stefano Malvestiti, Valter Agosti, Marco Rossi, Giosuè Costa, Gianluca Giavaresi, Abdel Kareem Azab, Antonia Cagnetta, Michele Cea, Pierosandro Tagliaferri, Antonino Neri, Nikhil C. Munshi, Giuseppe Viglietto, Pierfrancesco Tassone & Nicola Amodio. (2020) The Non-Coding RNA Landscape of Plasma Cell Dyscrasias. Cancers 12:2, pages 320.
Crossref
Silvia Catuogno, Maria Teresa Di Martino, Silvia Nuzzo, Carla Lucia Esposito, Pierfrancesco Tassone & Vittorio de Franciscis. (2019) An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery. Molecular Therapy - Nucleic Acids 18, pages 981-990.
Crossref
Raffaella Catalano, Roberta Rocca, Giada Juli, Giosuè Costa, Annalisa Maruca, Anna Artese, Daniele Caracciolo, Pierosandro Tagliaferri, Stefano Alcaro, Pierfrancesco Tassone & Nicola Amodio. (2019) A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine. European Journal of Medicinal Chemistry 183, pages 111715.
Crossref
Giada Juli, Manuela Oliverio, Dina Bellizzi, Maria Eugenia Gallo Cantafio, Katia Grillone, Giuseppe Passarino, Carmela Colica, Monica Nardi, Marco Rossi, Antonio Procopio, Pierosandro Tagliaferri, Pierfrancesco Tassone & Nicola Amodio. (2019) Anti-tumor Activity and Epigenetic Impact of the Polyphenol Oleacein in Multiple Myeloma. Cancers 11:7, pages 990.
Crossref
Cinzia Federico, Antonio Sacco, Angelo Belotti, Rossella Ribolla, Valeria Cancelli, Arianna Giacomini, Roberto Ronca, Marco Chiarini, Luisa Imberti, Mirella Marini, Giuseppe Rossi, Marco Presta, Bruno Paiva & Aldo M. Roccaro. (2019) Circulating microRNAs and Their Role in Multiple Myeloma. Non-Coding RNA 5:2, pages 37.
Crossref
Nicola Amodio, Maria Gallo Cantafio, Cirino Botta, Valter Agosti, Cinzia Federico, Daniele Caracciolo, Domenica Ronchetti, Marco Rossi, Christoph Driessen, Antonino Neri, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2019) Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma. Cancers 11:2, pages 236.
Crossref
Huimin Liu, Guihua Wang, Ying Huang, Chunmei Zhao, Jing Chen & Xudong Wang. (2018) Identification specific miRNA in t(4;14) multiple myeloma based on miRNA‐mRNA expressing profile correlation analysis. Journal of Cellular Biochemistry 120:2, pages 2454-2468.
Crossref
Nicola Amodio, Lavinia Raimondi, Giada Juli, Maria Angelica Stamato, Daniele Caracciolo, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2018) MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches. Journal of Hematology & Oncology 11:1.
Crossref
Mohammad Alzrigat, Alba Atienza Párraga & Helena Jernberg-Wiklund. (2018) Epigenetics in multiple myeloma: From mechanisms to therapy. Seminars in Cancer Biology 51, pages 101-115.
Crossref
Cinnie Soekojo, Sanjay de Mel, Melissa Ooi, Benedict Yan & Wee Chng. (2018) Potential Clinical Application of Genomics in Multiple Myeloma. International Journal of Molecular Sciences 19:6, pages 1721.
Crossref
Domenica Ronchetti, Luca Agnelli, Alessandro Pietrelli, Katia Todoerti, Martina Manzoni, Elisa Taiana & Antonino Neri. (2018) A compendium of long non-coding RNAs transcriptional fingerprint in multiple myeloma. Scientific Reports 8:1.
Crossref
Marco Rossi, Cirino Botta, Mariamena Arbitrio, Rosa Daniela Grembiale, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2018) Mouse models of multiple myeloma: technologic platforms and perspectives. Oncotarget 9:28, pages 20119-20133.
Crossref
Lucia Nobili, Domenica Ronchetti, Luca Agnelli, Elisa Taiana, Cristina Vinci & Antonino Neri. (2018) Long Non-Coding RNAs in Multiple Myeloma. Genes 9:2, pages 69.
Crossref
Maria Angelica Stamato, Giada Juli, Enrica Romeo, Domenica Ronchetti, Mariamena Arbitrio, Daniele Caracciolo, Antonino Neri, Pierosandro Tagliaferri, Pierfrancesco Tassone & Nicola Amodio. (2017) Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma. Oncotarget 8:63, pages 106527-106537.
Crossref
Stefanie Binder, Nadine Hösler, Diana Riedel, Ivonne Zipfel, Tilo Buschmann, Christoph Kämpf, Kristin Reiche, Renate Burger, Martin Gramatzki, Jörg Hackermüller, Peter F. Stadler & Friedemann Horn. (2017) STAT3-induced long noncoding RNAs in multiple myeloma cells display different properties in cancer. Scientific Reports 7:1.
Crossref
Chao Han, Jacson K. Shen, Francis J. Hornicek, Quancheng Kan & Zhenfeng Duan. (2017) Regulation of microRNA-1 (miR-1) expression in human cancer. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1860:2, pages 227-232.
Crossref
Shiying Li, Tianmei Qian, Xinghui Wang, Jie Liu & Xiaosong Gu. (2017) Noncoding RNAs and Their Potential Therapeutic Applications in Tissue Engineering. Engineering 3:1, pages 3-15.
Crossref
Pierosandro Tagliaferri, Mariamena Arbitrio, Antonella Ierardi, Domenico Ciliberto, Maria Teresa Di Martino & Pierfrancesco Tassone. 2017. Liquid Biopsy in Cancer Patients. Liquid Biopsy in Cancer Patients 7 26 .
Ana Herrero, Elizabeta Rojas, Irena Misiewicz-Krzeminska, Patryk Krzeminski & Norma Gutiérrez. (2016) Molecular Mechanisms of p53 Deregulation in Cancer: An Overview in Multiple Myeloma. International Journal of Molecular Sciences 17:12, pages 2003.
Crossref
Ehsan Malek, Byung‐Gyu Kim & James Driscoll. (2016) Identification of Long Non‐Coding RNAs Deregulated in Multiple Myeloma Cells Resistant to Proteasome Inhibitors. Genes 7:10, pages 84.
Crossref
Wen Lei, Shibing Wang, Chunmei Yang, Xianbo Huang, Zhenzhen Chen, Wei He, Jianping Shen, Xinyuan Liu & Wenbin Qian. (2016) Combined expression of miR-34a and Smac mediated by oncolytic vaccinia virus synergistically promote anti-tumor effects in Multiple Myeloma. Scientific Reports 6:1.
Crossref
M Fulciniti, N Amodio, R L Bandi, A Cagnetta, M K Samur, C Acharya, R Prabhala, P D'Aquila, D Bellizzi, G Passarino, S Adamia, A Neri, Z R Hunter, S P Treon, K C Anderson, P Tassone & N C Munshi. (2016) miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth. Blood Cancer Journal 6:1, pages e380-e380.
Crossref
Lavinia Raimondi, Angela De Luca, Eugenio Morelli, Gianluca Giavaresi, Pierosandro Tagliaferri, Pierfrancesco Tassone & Nicola Amodio. (2016) MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment. BioMed Research International 2016, pages 1-12.
Crossref
Maria Eugenia Gallo Cantafio, Boye Schnack Nielsen, Chiara Mignogna, Mariamena Arbitrio, Cirino Botta, Niels M Frandsen, Christian Rolfo, Pierosandro Tagliaferri, Pierfrancesco Tassone & Maria Teresa Di Martino. (2016) Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates. Molecular Therapy - Nucleic Acids 5, pages e326.
Crossref
M. Caraglia, C. Alaia, A. Grimaldi, M. Boccellino & L. Quagliuolo. 2016. Molecular Targets and Strategies in Cancer Prevention. Molecular Targets and Strategies in Cancer Prevention 151 171 .
Yiwei Li & Fazlul H. Sarkar. 2016. Molecular Targets and Strategies in Cancer Prevention. Molecular Targets and Strategies in Cancer Prevention 61 84 .
Nicola Amodio, Eugenio Morelli, Agnese Barone & Pierfrancesco Tassone. 2016. Molecular Targets and Strategies in Cancer Prevention. Molecular Targets and Strategies in Cancer Prevention 37 60 .
Pietro H Guzzi, Maria Teresa Di Martino, Pierosandro Tagliaferri, Pierfrancesco Tassone & Mario Cannataro. (2015) Analysis of miRNA, mRNA, and TF interactions through network-based methods. EURASIP Journal on Bioinformatics and Systems Biology 2015:1.
Crossref
E Morelli, E Leone, M E Gallo Cantafio, M T Di Martino, N Amodio, L Biamonte, A Gullà, U Foresta, M R Pitari, C Botta, M Rossi, A Neri, N C Munshi, K C Anderson, P Tagliaferri & P Tassone. (2015) Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo. Leukemia 29:11, pages 2173-2183.
Crossref
Bin Yu, Songlin Zhou, Sheng Yi & Xiaosong Gu. (2015) The regulatory roles of non-coding RNAs in nerve injury and regeneration. Progress in Neurobiology 134, pages 122-139.
Crossref
Maria Rita Pitari, Marco Rossi, Nicola Amodio, Cirino Botta, Eugenio Morelli, Cinzia Federico, Annamaria Gullà, Daniele Caracciolo, Maria Teresa Di Martino, Mariamena Arbitrio, Antonio Giordano, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2015) Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts. Oncotarget 6:29, pages 27343-27358.
Crossref
Mariarosaria Boccellino, Concetta Alaia, Gabriella Misso, Alessia Maria Cossu, Gaetano Facchini, Raffaele Piscitelli, Lucio Quagliuolo & Michele Caraglia. (2015) Gene interference strategies as a new tool for the treatment of prostate cancer. Endocrine 49:3, pages 588-605.
Crossref
Vittorio Simeon, Katia Todoerti, Francesco La Rocca, Antonella Caivano, Stefania Trino, Marta Lionetti, Luca Agnelli, Luciana De Luca, Ilaria Laurenzana, Antonino Neri & Pellegrino Musto. (2015) Molecular Classification and Pharmacogenetics of Primary Plasma Cell Leukemia: An Initial Approach toward Precision Medicine. International Journal of Molecular Sciences 16:8, pages 17514-17534.
Crossref
Qi Zhang, Lu Qian Wang, Kwan Yeung Wong, Zhen Yu Li & Chor Sang Chim. (2015) Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma . Journal of Clinical Pathology 68:7, pages 557-561.
Crossref
Marco Rossi, Teresa Calimeri, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2015) Multiple myeloma-related bone disease: state-of-art and next future treatments. International Journal of Hematologic Oncology 4:1, pages 33-47.
Crossref
Alfons Navarro, Tania Díaz, Natalia Tovar, Fabiola Pedrosa, Rut Tejero, María Teresa Cibeira, Laura Magnano, Laura Rosiñol, Mariano Monzó, Joan Bladé & Carlos Fernández de Larrea. (2015) A serum microRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma. Oncotarget 6:3, pages 1874-1883.
Crossref
Maria Teresa Di Martino, Nicola Amodio, Pierfrancesco Tassone & Pierosandro Tagliaferri. 2016. Microarray Data Analysis. Microarray Data Analysis 181 194 .
Jahangir Abdi, Lugui Qiu & Hong Chang. (2014) Micro-RNAs, New performers in multiple myeloma bone marrow microenvironment. Biomarker Research 2:1.
Crossref
Marzia Leotta, Lavinia Biamonte, Lavinia Raimondi, Domenica Ronchetti, Maria Teresa Di Martino, Cirino Botta, Emanuela Leone, Maria Rita Pitari, Antonino Neri, Antonio Giordano, Pierosandro Tagliaferri, Pierfrancesco Tassone & Nicola Amodio. (2014) A p53-Dependent Tumor Suppressor Network Is Induced by Selective miR-125a-5p Inhibition in Multiple Myeloma Cells. Journal of Cellular Physiology 229:12, pages 2106-2116.
Crossref
Maria Teresa Di Martino, Virginia Campani, Gabriella Misso, Maria Eugenia Gallo Cantafio, Annamaria Gullà, Umberto Foresta, Pietro Hiram Guzzi, Maria Castellano, Anna Grimaldi, Vincenzo Gigantino, Renato Franco, Sara Lusa, Mario Cannataro, Pierosandro Tagliaferri, Giuseppe De Rosa, Pierfrancesco Tassone & Michele Caraglia. (2014) In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma. PLoS ONE 9:2, pages e90005.
Crossref
Maria Teresa Di Martino, Annamaria Gullà, Maria Eugenia Gallo Cantafio, Emanuela Altomare, Nicola Amodio, Emanuela Leone, Eugenio Morelli, Santo Giovanni Lio, Daniele Caracciolo, Marco Rossi, Niels M. Frandsen, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2014) In Vitro and In Vivo Activity of a Novel Locked Nucleic Acid (LNA)-Inhibitor-miR-221 against Multiple Myeloma Cells. PLoS ONE 9:2, pages e89659.
Crossref
Gabriella Misso, Maria Teresa Di Martino, Giuseppe De Rosa, Ammad Ahmad Farooqi, Angela Lombardi, Virginia Campani, Mayra Rachele Zarone, Annamaria Gullà, Pierosandro Tagliaferri, Pierfrancesco Tassone & Michele Caraglia. (2014) Mir-34: A New Weapon Against Cancer?. Molecular Therapy - Nucleic Acids 3, pages e195.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.